-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Merck & Co, Raises Price Target to $161

Benzinga·09/09/2026 16:03:01
Listen to the news
Leerink Partners analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $127 to $161.